셀룰로오스-그라프트-폴리락타이드계 양친매성 중합체에 기반한 고분자 마이셀-약물 복합체 및 이의 제조 방법
    1.
    发明公开
    셀룰로오스-그라프트-폴리락타이드계 양친매성 중합체에 기반한 고분자 마이셀-약물 복합체 및 이의 제조 방법 无效
    基于纤维素 - 聚酰胺的聚合物的聚合物MICELLE-MEDICINE复合物及其制备方法

    公开(公告)号:KR1020140102456A

    公开(公告)日:2014-08-22

    申请号:KR1020130015768

    申请日:2013-02-14

    CPC classification number: A61K47/61 A61K9/127 A61K31/573 A61K2121/00

    Abstract: The present invention relates to a polymer micelle-medicine complex based on a cellulose-graft-polylactide-based amphiphilic polymer and to a method for producing the same. More specifically, the polymer micelle-medicine complex includes an amphiphilic copolymer having a hydrophilic block including cellulose and a hydrophobic block including polylactide and is formed in a core-shell structure consisting of a hydrophobic core unit and a hydrophilic shell unit. Prednisolone acetate which is a refractory drug is encapsulated in the core unit of the core-shell structure so as to constitute the polymer micelle-medicine complex. The polymer micelle-medicine complex according to the present invention effectively solubilizes the refractory drug and changes the molecular variants of the amphiphilic copolymer so that a micelle having improved stability is produced. Accordingly, the encapsulation efficiency of the refractory drug is maximized and releasing behavior can be easily controlled.

    Abstract translation: 本发明涉及基于纤维素接枝聚丙交酯的两亲聚合物的聚合物胶束 - 药物复合物及其制备方法。 更具体地,聚合物胶束 - 药物复合物包括具有包含纤维素的亲水性嵌段和包含聚丙交酯的疏水性嵌段的两亲共聚物,并且形成在由疏水性核心单元和亲水性壳单元组成的核 - 壳结构中。 作为难治性药物的醋酸泼尼松龙被封装在芯 - 壳结构的核心单元中,以构成聚合物胶束 - 药物复合物。 根据本发明的聚合物胶束 - 药物复合物有效地溶解耐火药物并改变两亲性共聚物的分子变体,从而产生具有改善的稳定性的胶束。 因此,耐火药物的包封效率最大化,并且可以容易地控制释放行为。

    표면이 비누화된 단분산성 미세구형 수화겔 입자의 제조방법
    2.
    发明公开
    표면이 비누화된 단분산성 미세구형 수화겔 입자의 제조방법 有权
    具有岐化表面的单稳态微型水凝胶颗粒的制备方法

    公开(公告)号:KR1020100027568A

    公开(公告)日:2010-03-11

    申请号:KR1020080086537

    申请日:2008-09-03

    CPC classification number: C08F263/04 C08F8/12 C08F261/04 C08J3/075 C08J3/12

    Abstract: PURPOSE: A fabrication method of monodisperse microball-shaped hydrogel particles is provided to prepare polymer particles using relatively inexpensive water-soluble dispersing stabilizers and a large amount of water as a polymerization solvent through a single process. CONSTITUTION: A fabrication method of monodisperse microball-shaped hydrogel particles comprises the steps of: forming monodispersed polyvinyl acetate microspheres using dispersion polymerization of vinyl acetate monomers; and saponifying the polyvinyl acetate microspheres from a dispersing medium in the same arrangement state so that the polyvinyl acetate microspheres have a dual structure of a polyvinyl acetate/polyvinyl alcohol shell.

    Abstract translation: 目的:提供单分散微球形水凝胶颗粒的制造方法,通过单一工艺使用相对便宜的水溶性分散稳定剂和大量的水作为聚合溶剂制备聚合物颗粒。 构成:单分散微球状水凝胶颗粒的制造方法包括以下步骤:使用乙酸乙烯酯单体的分散聚合形成单分散的聚乙酸乙烯酯微球; 并以相同的布置状态从分散介质中皂化聚乙酸乙烯酯微球,使得聚乙酸乙烯酯微球具有聚乙酸乙烯酯/聚乙烯醇壳的双重结构。

    수술용 메쉬 및 이의 제조방법
    4.
    发明公开
    수술용 메쉬 및 이의 제조방법 无效
    手术网及其制造方法

    公开(公告)号:KR1020100022237A

    公开(公告)日:2010-03-02

    申请号:KR1020080080813

    申请日:2008-08-19

    CPC classification number: A61L17/005 A61L17/10 A61L31/00

    Abstract: PURPOSE: A surgical mesh and a method for manufacturing the mesh are provided to obtain an operation convenience by maintaining an initial strength and a rigidity of a conventional polypropylene surgical mesh, to minimize inflammation caused by neophobia after the operation, and obtain excellent biocompatibility by helping a fast growth of a cell. CONSTITUTION: A surgical mesh comprises: a mesh main body; and a coating layer which is coated on the surface of the mesh main body and includes a bioactive substance. The coating layer more includes an adhesive material. The adhesive material is a biodegradable polymer. The bioactive substance is an anti-inflammatory agent, an antioxidant or a mixture of the anti-inflammatory agent and the antioxidant. The anti-inflammatory agent is dexamethasone, prednisolone, aspirin, ibuprofen, indomethacin or naproxen.

    Abstract translation: 目的:提供外科手术网及其制造方法,通过维持常规聚丙烯外科手术网的初始强度和刚度,使操作后由于恐惧症引起的炎症减到最小,从而获得操作便利性,并通过帮助获得优异的生物相容性 细胞生长快速。 构成:外科手术网包括:网状主体; 以及涂布在网状物主体的表面上并包含生物活性物质的涂层。 涂层更包括粘合剂材料。 粘合剂材料是可生物降解的聚合物。 生物活性物质是抗炎剂,抗氧化剂或抗炎剂和抗氧化剂的混合物。 抗炎剂是地塞米松,泼尼松龙,阿司匹林,布洛芬,吲哚美辛或萘普生。

    방향오일을 함유하는 실리카 나노입자의 제조방법
    5.
    发明公开
    방향오일을 함유하는 실리카 나노입자의 제조방법 无效
    含二氧化硅纳米脂含油的制备方法

    公开(公告)号:KR1020100021028A

    公开(公告)日:2010-02-24

    申请号:KR1020080079723

    申请日:2008-08-14

    CPC classification number: C01B33/12 B82Y30/00 B82Y40/00 C01B33/14 C01P2004/64

    Abstract: PURPOSE: A method for preparing silica nanoparticles imparting thermal stability and mechanical strength by encapsulating aromatic oil with silica. CONSTITUTION: A method for preparing silica nanoparticles comprises the steps of: (i) forming an emulsion solution by adding surfactant, cosurfactant and aromatic oil to water; and (ii) adding a silica precursor to an emulsion solution to obtain silica nanoparticles. The surfactant is added in the amount of 1-4 weight% based on water. The cosurfactant is added in the amount of 1-10 volume % based on water.

    Abstract translation: 目的:制备二氧化硅纳米粒子的方法,通过用二氧化硅包封芳香油赋予热稳定性和机械强度。 构成:制备二氧化硅纳米粒子的方法包括以下步骤:(i)通过向水中加入表面活性剂,辅助表面活性剂和芳香油形成乳液; 和(ii)向乳液溶液中加入二氧化硅前体以获得二氧化硅纳米颗粒。 表面活性剂的添加量为1-4重量%,基于水。 辅助表面活性剂的添加量为1-10体积%,基于水。

Patent Agency Ranking